Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Ellen_Donnelly
|
| gptkbp:country |
gptkb:Sweden
|
| gptkbp:developedBy |
treatments for primary mitochondrial diseases
|
| gptkbp:focusesOn |
mitochondrial medicine
|
| gptkbp:formerName |
gptkb:NeuroVive_Pharmaceutical_AB
|
| gptkbp:founded |
2000
|
| gptkbp:headquarters_location |
gptkb:Lund
|
| https://www.w3.org/2000/01/rdf-schema#label |
Abliva
|
| gptkbp:listedOn |
gptkb:Nasdaq_Stockholm
|
| gptkbp:website |
https://abliva.com
|
| gptkbp:bfsParent |
gptkb:Institut_Mérieux_group
|
| gptkbp:bfsLayer |
6
|